CIK 0001730463 · Non-accelerated filer<br>Smaller reporting company
Autolus Therapeutics plc
Sign in to watch- Ticker
- AUTL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 20 3829 6230
- Business address
- THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
- Former names
- Autolus Therapeutics Ltd
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- POSASR Other POSASR
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- SC 13G Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
Page 6 of 17 · 340 filings